However, insufficient information directly examining SARS-CoV-2 antigen-specific CD4+ T cells, CD8+ T cells, and neutralizing antibodies in the same acute patients is hindering our understanding of the roles of adaptive immunity in acute COVID-19 protection or pathogenesis. The gene discussed is CD4; the disease is COVID-19.